- cafead   Aug 22, 2023 at 11:52: PM
via Novavax’s vaccine candidate against new sublineages of COVID-19 is showing promising results in small animal and non-human primate studies. The company announced Tuesday that its XBB COVID vaccine candidate induced neutralizing antibody responses in the EG.5.1 and XBB.1.16.6 subvariants, dubbed Eris and Fornax, respectively.
article source
article source